Evidence map›Paper›PMID 31077341›Full record

ArticleBritish journal of pharmacology2019

Second M

Loes E M Kistemaker, Carolina R S Elzinga, Christofer S Tautermann, Michael P Pieper, Daniel Seeliger, Suraya Alikhil, Martina Schmidt, Herman Meurs, Reinoud Gosens

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Second MBritish journal of pharmacology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Loes E M KistemakerDepartment of Molecular Pharmacology, University of Groningen, Groningen, The Netherlands.ORCID 0000-0002-7742-8748
Carolina R S ElzingaDepartment of Molecular Pharmacology, University of Groningen, Groningen, The Netherlands.
Christofer S TautermannDepartment of Medicinal Chemistry, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.
Michael P PieperImmunology and Respiratory Disease Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.
Daniel SeeligerDepartment of Medicinal Chemistry, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.
Suraya AlikhilDepartment of Molecular Pharmacology, University of Groningen, Groningen, The Netherlands.
Martina SchmidtDepartment of Molecular Pharmacology, University of Groningen, Groningen, The Netherlands.
Herman MeursDepartment of Molecular Pharmacology, University of Groningen, Groningen, The Netherlands.
Reinoud GosensDepartment of Molecular Pharmacology, University of Groningen, Groningen, The Netherlands.
University Medical Center Groningen · NLBoehringer Ingelheim (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeThe bronchodilator tiotropium binds not only to its main binding site on the M EXPERIMENTAL APPROACH: ACh, tiotropium, and atropine binding to M KEY

resultsMolecular dynamics simulation revealed extracellular vestibule binding of tiotropium, and not atropine, to M CONCLUSIONS AND IMPLICATIONS: We propose that tiotropium has two binding sites at the M

Indexed as

AcetylcholineAdrenergic beta-2 Receptor AgonistsAnimalsBinding SitesBronchodilator AgentsCattleCholinergic AntagonistsHumansIn Vitro TechniquesMolecular Dynamics SimulationReceptor, Muscarinic M3Tiotropium BromideTracheaAcetylcholineAdrenergic beta-2 Receptor AgonistsBronchodilator AgentsCholinergic AntagonistsReceptor, Muscarinic M3Tiotropium Bromide

Identifiers

PMID31077341
PMCPMC6637226
OpenAlexW2944207598

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.